VulnerabilityModified
CVE-2023-38954
ZKTeco BioAccess IVS v3.3.1 was discovered to contain a SQL injection vulnerability.
CRITICAL 9.8EPSS 0.61%
Does this matter?
High impact if exploited, but EPSS currently rates exploitation as unlikely (0.61%). Schedule it in the normal patch cycle and watch for a rise in EPSS or a public exploit.
Description
ZKTeco BioAccess IVS v3.3.1 was discovered to contain a SQL injection vulnerability.
- CVSS 3.1
- 9.8 CRITICALCVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
- EPSS
- 0.61% probability · 47th percentile
- CISA KEV
- Not listed
- Weakness
- CWE-89
- Affected
- zkteco/bioaccess ivs
- Source
- cve@mitre.org
References
- https://claroty.com/team82/disclosure-dashboard/cve-2023-38954Third Party Advisory
- https://claroty.com/team82/disclosure-dashboard/cve-2023-38954Third Party Advisory
Source: NVD record, EPSS from FIRST.org, KEV from CISA. Refreshed daily.